Trials are meaningful for clinical decision making only when their endpoints are valid and comparable

Br J Dermatol. 2015 May;172(5):1175-7. doi: 10.1111/bjd.13806.

Author

J Schmitt^{1

2}

Affiliations

¹ Centre for Evidence-Based Healthcare, Medizinische Fakultät Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany. Jochen.Schmitt@uniklinikum-dresden.de.
² Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, NG7 2NR, U.K.. Jochen.Schmitt@uniklinikum-dresden.de.

PMID: 25963201
DOI: 10.1111/bjd.13806

No abstract available

Publication types

Editorial
Comment

MeSH terms

Dermatitis, Atopic / diagnosis*
Humans
Severity of Illness Index*